Perceptive Advisors
$5.0B Assets Reported
129 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 2,035,986 | $656M | 13.0% |
| CELC | CELCUITY INC | 3,127,200 | $357M | 7.1% |
| ASND | ASCENDIS PHARMA A/S | 1,531,421 | $350M | 6.9% |
| ROIV | ROIVANT SCIENCES LTD | 8,285,461 | $230M | 4.5% |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 5,258,903 | $209M | 4.1% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,373,795 | $206M | 4.1% |
| SYRE | SPYRE THERAPEUTICS INC | 3,783,225 | $191M | 3.8% |
| NUVL | NUVALENT INC | 1,580,505 | $162M | 3.2% |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,423,974 | $139M | 2.8% |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,230,879 | $130M | 2.6% |
Track Perceptive Advisors's 13F portfolio: $5.0B in reported holdings, 129 positions. Top holdings, AUM, and quarterly changes on SentiSense.